nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Bioactive Materials Facilitating Targeted Local Modulation of Inflammation
|
Tan, Richard P. |
|
|
4 |
1 |
p. 56-71 |
artikel |
2 |
Cardiomyocyte SMAD4-Dependent TGF-β Signaling is Essential to Maintain Adult Heart Homeostasis
|
Umbarkar, Prachi |
|
|
4 |
1 |
p. 41-53 |
artikel |
3 |
Chest Compressions During Sustained Inflation During Cardiopulmonary Resuscitation in Newborn Infants Translating Evidence From Animal Studies to the Bedside
|
Schmölzer, Georg M. |
|
|
4 |
1 |
p. 116-121 |
artikel |
4 |
Circulating Pro-Vascular Progenitor Cell Depletion During Type 2 Diabetes
|
Terenzi, Daniella C. |
|
|
4 |
1 |
p. 98-112 |
artikel |
5 |
Connecting the Dots for Connective Tissue Growth Factor Roles in Cardiac Wound Healing After Myocardial Infarction ∗
|
Hale, Taben M. |
|
|
4 |
1 |
p. 95-97 |
artikel |
6 |
Connective Tissue Growth Factor Inhibition Enhances Cardiac Repair and Limits Fibrosis After Myocardial Infarction
|
Vainio, Laura E. |
|
|
4 |
1 |
p. 83-94 |
artikel |
7 |
Correction
|
|
|
|
4 |
1 |
p. 134 |
artikel |
8 |
Dipeptidyl Peptidase-4 Inhibition Prevents Vascular Calcification by Potentiating the Insulin-Like Growth Factor-1 Signaling Pathway
|
Varennes, Olivier |
|
|
4 |
1 |
p. 113-115 |
artikel |
9 |
Editorial Board
|
|
|
|
4 |
1 |
p. i-iii |
artikel |
10 |
Empagliflozin Improves Diastolic Function in a Nondiabetic Rodent Model of Heart Failure With Preserved Ejection Fraction
|
Connelly, Kim A. |
|
|
4 |
1 |
p. 27-37 |
artikel |
11 |
Full Issue PDF
|
|
|
|
4 |
1 |
p. I-CXLII |
artikel |
12 |
Instructions For Authors
|
|
|
|
4 |
1 |
p. iv-viii |
artikel |
13 |
It’s a SMAD, SMAD World
|
Bradshaw, Amy D. |
|
|
4 |
1 |
p. 54-55 |
artikel |
14 |
miR-29b Mediates the Chronic Inflammatory Response in Radiotherapy-Induced Vascular Disease
|
Eken, Suzanne M. |
|
|
4 |
1 |
p. 72-82 |
artikel |
15 |
Neutrophil Subsets, Platelets, and Vascular Disease in Psoriasis
|
Teague, Heather L. |
|
|
4 |
1 |
p. 1-14 |
artikel |
16 |
SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart
|
Lim, Ven G. |
|
|
4 |
1 |
p. 15-26 |
artikel |
17 |
The Growing Case for Use of SGLT2i in Heart Failure
|
Ha, Chae-Myeong |
|
|
4 |
1 |
p. 38-40 |
artikel |
18 |
Therapeutic Genome Editing in Cardiovascular Diseases
|
German, David M. |
|
|
4 |
1 |
p. 122-131 |
artikel |
19 |
What Are the Off-Target Effects of Plan “S” For Translational Investigators?
|
Mann, Douglas L. |
|
|
4 |
1 |
p. 132-133 |
artikel |